MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GUTS — Fractyl Health, Inc. Common Stock
NasdaqFractyl Health, Inc. Common Stock
$0.41
-0.04(-9.66%)
- O
- 0.45
- H
- 0.45
- L
- 0.40
- V
- 2.95M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About GUTS
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateFeb 2, 2024
Employees73
Stock ExchangeNasdaq
Ticker SymbolGUTS
Websitehttps://www.fractyl.com
Key Financial Statistics
| Market Cap | $64.72M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.38 - $2.45 |
| 52-Week Avg Volume | 3.00M |
| VWAP | $0.41 |
| Transactions | 9,716 |
| Total Recorded Bars | 669 days |